Off-the-Shelf Vaccine for Pancreatic and Colon Cancer Tested
A recent study published in Nature Medicine showed that a new off-the-shelf cancer vaccine helped the body’s immune system fight cancer in patients with pancreatic and colon cancer. In a Phase 1 clinical trial, the vaccine showed positive results, especially in preventing recurrence of cancer after treatment, boosting survival in patients who had surgery to […]
COVID-19 Boosters Linked to More Illness and Absenteeism in Health Care Workers
A new peer-reviewed Swiss study has found that recent COVID-19 booster shots were linked to higher short-term illness risk and absenteeism among health care workers, raising questions about he benefits of universal booster campaigns, particularly in populations at low risk for COVID complications. The cohort study was published on Aug. 9, 2025 in the journal […]
Children in America 80 Percent More Likely to Die Than Children in Other Industrialized Countries
The United States is confronting a growing pediatric health crisis, with mounting evidence pointing to a decline in children’s overall health and wellbeing. A recent study revealed that children in the U.S. are dying at significantly higher rates than their peers in other high-income nations, underscoring the severity of the issue.1 2 The cross-sectional study […]
Parents in Michigan Delaying Childhood Vaccination Due to Safety Concerns
The Michigan Department of Health and Human Services (MDHHS), in partnership with Michigan based I Vaccinate campaign, conducted a statewide survey in spring 2025 of parents with children under the age of six. The survey found that while most Michigan parents keep their children up to date on routine vaccinations, those who fall behind are […]
ACIP Majority Ignores Risks and Recommends Infants Get Merck’s RSV Monoclonal Antibody
On June 25, 2025, the majority of members of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ignored risk warnings and voted for a recommendation that infants be given Merck & Co.’s monoclonal antibody, clesrovimab, marketed as Enflonsia. The committee advised using Enflonsia to prevent Respiratory Syncytial Virus […]
Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
A novel class of therapies that are labeled vaccines—known as ‘inverse vaccines’—are designed to treat autoimmune disorders and could be made available in just a few years. In January, Swiss biotech company Anokion—which focuses on improving treatments and health outcomes for individuals suffering with autoimmune disorders—announced promising early human trials of inverse “vaccines” targeting celiac […]